Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints ...
Joshua Cohen is a Boston-based writer who covers health policy. Patients on the weight-loss drug Zepbound regained weight almost one year after stopping treatment, according to a study published ...
(Zepbound is one of the medication's brand names.) Men, meanwhile, lost 19 percent of their body weight. This is a big move in the weight loss space. Here’s what you need to know about Zepbound.